| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055474 Novel molecules of the tnf ligand superfamily and uses therefor |
| 05/09/2002 | US20020055467 Truncated neublastin, of the glial cell-derived nerve growth factor (GDNF) subfamily; when dimerized, binds to a RET (a receptor tyrosine kinase) polypeptide |
| 05/09/2002 | US20020055466 Terpolymer of tyrosine, alanine and lysine randomly polymerized into a polypeptide |
| 05/09/2002 | US20020055463 Peptidomimetics for Grb2 (growth factor receptor binding protein); treating cancer, metastasis and proliferative disorders |
| 05/09/2002 | US20020055459 Beta-site APP (Amyloid Precursor Protein) Cleaving Enzyme (BACE); using computer to screen for drugs using active site information; Alzheimer's disease |
| 05/09/2002 | US20020055419 System and method to improve fitness training |
| 05/09/2002 | US20020055183 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 05/09/2002 | US20020055174 Complex for transferring an anionic substance of interest into a cell |
| 05/09/2002 | US20020055173 Plasmids for use in expressing heterologous proteins on surface viral particle and for use in gene therapy |
| 05/09/2002 | US20020055169 Method for expression of heterologous proteins in yeast |
| 05/09/2002 | US20020055168 Streptococcus suis vaccines and diagnostic tests |
| 05/09/2002 | US20020055158 Human tissue inhibitor of metalloproteinase-4 |
| 05/09/2002 | US20020055156 Zsig33-like peptides |
| 05/09/2002 | US20020055154 Nucleotide sequences which code for the acp gene |
| 05/09/2002 | US20020055153 L-lysine-producing corynebacteria and process for the preparation of lysine |
| 05/09/2002 | US20020055148 Cloning method for DNA fragments using arbitrarily primed PCR |
| 05/09/2002 | US20020055147 Nucleotide sequences coding cytokine; for use in the treatment of immunological defects, allergies, asthma and arthritis |
| 05/09/2002 | US20020055145 Isolating preferential polypeptide; obtain sample, incubate with ion exchange resin, elute, recover polypeptide |
| 05/09/2002 | US20020055144 Human hematopoietic-specific protein |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055141 Genetically engineered microorgaism for use as diagnostic tool |
| 05/09/2002 | US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 05/09/2002 | US20020055139 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 05/09/2002 | US20020055138 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 05/09/2002 | US20020055137 Methods for detecting nucleic acid molecules encoding flh2882, a GPCR showing homology to the 5HT family of receptors |
| 05/09/2002 | US20020055136 Soluble recombinant alpha beta adhesion receptor |
| 05/09/2002 | US20020055129 Antibodies for the alpha platelet-derived growth factor receptor |
| 05/09/2002 | US20020055128 Measuring binding of a candidate compound to the polypeptide (or to the cells or membranes bearing the polypeptide) or a fusion protein by means of a label associated with candidate compound, measuring binding, testing signal generated |
| 05/09/2002 | US20020055121 Combining a sample from human host with antibodies or antibody fragments which bind specificallly to a peptide having preferential amino acid sequence and detecting the formation of immune complexes indicative of melanoma cells |
| 05/09/2002 | US20020055115 Nucleotide sequences coding for the Dep33 efflux protein |
| 05/09/2002 | US20020055114 Nucleotide sequences coding for the chrS protein |
| 05/09/2002 | US20020055108 CDNA, protein, and antibodies in the diagnosis, prognosis, treatment and evaluaation of therapies for cancers and neurodegenerative disorders |
| 05/09/2002 | US20020055107 Cancer diagnosis method using cell growth inhibiting and cell differentiation specific SYG972 gene and genomic DNA and promoter thereof |
| 05/09/2002 | US20020055106 Method for generating hypermutable organisms |
| 05/09/2002 | US20020055101 Oligonucleotide sequences which can be used as probes or amplification primers for polymerase chain reaction |
| 05/09/2002 | US20020055099 Sequential cdna library and uses thereof |
| 05/09/2002 | US20020054916 Comprising ceruloplasmin and a serum-derived composition (SDF) having a low molecular weight, electrically charged at acidic pH and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 05/09/2002 | US20020054887 Toxin has at least one amino acid change and is substantially non-lethal compared with wild type SPE-A toxin; for vaccines |
| 05/09/2002 | US20020054886 For treatment of disseminated candidiasis due to infection by C.albicans; monoclonal antibodies for use in passive immunization against candidal infections |
| 05/09/2002 | US20020054885 Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth |
| 05/09/2002 | US20020054883 Recombinant fusobacterium necrophorum leukotoxin vaccine and preparation thereof |
| 05/09/2002 | US20020054882 Anti-human influenza virus antibody |
| 05/09/2002 | US20020054881 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 05/09/2002 | US20020054880 Suppressing inflammatory response in mammal by the administration of lectin derived carbohydrate binding peptide capable of binding terminally linked alpha-sialic acid derivative |
| 05/09/2002 | US20020054877 Mammalian cytokine; related reagents |
| 05/09/2002 | US20020054876 Treatment of Alzheimer's disease |
| 05/09/2002 | US20020054874 Exposing cells having the trk (neurotrophin) receptor to a multivalent immunoglobulin which binds to the receptor and activates the receptor by inducing increase in phosphorylation of the receptor |
| 05/09/2002 | US20020054872 Peptides for the treatment of systemic lupus erythematosus and methods of treating systemic lupus erythematosus |
| 05/09/2002 | US20020054871 Treating a host suffering from hyperlipidemia resulting from elevated levels of at least one of very low density lipoproteins and triglycerides and effective amount of an agent that reduces the level of active apolipoprotein E |
| 05/09/2002 | US20020054865 An anaerobic bacterium belonging to the genus Bifidobacterium capable of expressing a gene coding for a protein having an antitumor activity in only cancer cells under anaerobic conditions; reduced toxicity |
| 05/09/2002 | US20020054855 Gastrin receptor-avid peptide conjugates |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203817A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 05/08/2002 | EP1203816A1 Amyloid beta protein agglutination controlling factor |
| 05/08/2002 | EP1203813A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203812A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203775A2 Lymphocyte chemoattractant factor and uses thereof |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1203591A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 05/08/2002 | EP1203239A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 05/08/2002 | EP1203101A1 Ppar delta links apc to chemopreventive drugs |
| 05/08/2002 | EP1203086A2 Mites-like element and transcriptional activation element |
| 05/08/2002 | EP1203082A1 Recombinant high molecular weight major outer membrane protein of moraxella |
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203078A2 Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat |
| 05/08/2002 | EP1203077A1 TRANSGENIC PLANTS EXPRESSING i PHOTORHABDUS /i TOXIN |
| 05/08/2002 | EP1203025A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND $g(b)1 INTEGRINS |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203022A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 05/08/2002 | EP1203021A2 NEW SEQUENCE VARIANTS OF THE HUMAN $g(b)1-ADRENORECEPTOR GENES AND USE THEREOF |
| 05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
| 05/08/2002 | EP1203019A1 Peptides containing n-substituted l-amino acids for preventing beta-strand association |
| 05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
| 05/08/2002 | EP1203017A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 |
| 05/08/2002 | EP1203016A2 Proteases and protease inhibitors |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203014A2 Peptide antagonists of factor viia |
| 05/08/2002 | EP1203013A1 Kinase blocking polypeptides and uses thereof |
| 05/08/2002 | EP1203012A2 Refolding of membrane proteins using two different detergents |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1202629A2 Insect control system |
| 05/08/2002 | EP1092021A4 Npy-y7 receptor gene |
| 05/08/2002 | EP1062366A4 Detection of neoplasia by analysis of saliva |
| 05/08/2002 | EP1011319A4 A method of treatment and an animal model useful for same |
| 05/08/2002 | EP0998299A4 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/08/2002 | EP0895545A4 Novel protein - traf6 |
| 05/08/2002 | EP0789783B1 Antigen binding peptides (abtides) from peptide libraries |
| 05/08/2002 | EP0759933B1 Beta sheet forming peptides and gels made thereof |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | EP0625053B1 Urease-based vaccine against helicobacter infection |
| 05/08/2002 | DE10054878A1 Natriumkanäle vom Typus der peripheren Nerven Sodium channels of the type of peripheral nerves |
| 05/08/2002 | DE10053870A1 Procollagen (III)-Propeptide und verwandte Substanzen zur Behandlung von fibrotischen Erkrankungen Procollagen (III) propeptides and related substances for the treatment of fibrotic diseases |
| 05/08/2002 | DE10053251A1 New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases |
| 05/08/2002 | DE10053224A1 Verfahren zur Exposition von Peptiden und Polypeptiden auf der Zelloberfläche von Bakterien A process for the exposure of peptides and polypeptides on the cell surface of bacteria |
| 05/08/2002 | DE10051259A1 Non-human mammal with altered pituitary adenylate cyclase-activating polypeptide receptor, useful e.g. as screening agents for treating e.g. learning difficulties |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348495A Cotton leaf curl virus (CLCuV) promoter and its use |